BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
CYP51
,
Metabolism of xenobiotics
,
Allergy to pollen
,
Lymphocyte
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
neuroendocrine carcinoma
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Classification of High-grade neuroendocrine tumors of the lung
Merkel cell carcinoma MKL-1 cells with shRNA mediated doxycycline inducible MUC1 knockdown
Neuroendocrine carcinoma MKL-1 cells with doxycycline-induced EP400 and MYCL shRNA knockdown
Merkel cell carcinoma MKL-1 cells with doxycycline-inducible expression of EP400 shRNA
Small cell and non-small cell lung cancer cell lines profiled by histology, gender, and ancestry
Explore Curated Studies Results
Literature
Most Relevant Literature
Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view.
Large cell neuroendocrine carcinoma of the lung: is it possible to diagnose from biopsy specimens?
Primary neuroendocrine carcinoma of the appendix: a case report and review of the literature.
Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
Neuroendocrine carcinoma of the thyroid causing adrenocorticotrophic hormone-dependent Cushing's syn…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas
Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)
Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma
FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas
Atezolizumab in Large Cell Neuroendocrine Carcinoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ